Grant Edward A 4
4 · Obagi Medical Products, Inc. · Filed Apr 29, 2013
Insider Transaction Report
Form 4
Grant Edward A
Director
Transactions
- Disposition to Issuer
Common Stock
2013-04-25$24.00/sh−18,996$455,904→ 2,206 total - Disposition to Issuer
Common Stock
2013-04-25$24.00/sh−2,206$52,944→ 0 total
Footnotes (1)
- [F1]At the effective time of the merger, these shares of restricted stock immediately vested in full and were converted into the right to receive $24.00 per share in cash, without interest (less any applicable withholding tax), under the terms of the Agrement and Plan of Merger, dated as of March 19, 2013, among the issuer, Odysseus Acquisition Corp, Valeant Pharmaceuticals International and Valeant Pharmaceuticals International, Inc., as amended, and the issuer's 2005 Stock Incentive Plan, as amended, and as approved by the issuer's Board of Directors.